# ClinicalTrials.gov record NCT07009860

> PeptideScanner retained ClinicalTrials.gov record NCT07009860 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was pemvidutide.

- Evidence object: `story:clinicaltrials-gov-nct07009860-pemvidutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07009860-pemvidutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07009860-pemvidutide-v1.json
- Content SHA-256: `699f0aa1405b07ff0fd36a6e4f3b654877ffc1aec72a52063a857392274f123d`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07009860 ([`ctg-observation-nct07009860-2026-03-20-c02a1977625c`](#source-ctg-observation-nct07009860-2026-03-20-c02a1977625c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07009860 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct07009860-2026-03-20-c02a1977625c`](#source-ctg-observation-nct07009860-2026-03-20-c02a1977625c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07009860 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct07009860-2026-03-20-c02a1977625c`](#source-ctg-observation-nct07009860-2026-03-20-c02a1977625c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07009860-2026-03-20-c02a1977625c`](#source-ctg-observation-nct07009860-2026-03-20-c02a1977625c))

## Sources

<a id="source-ctg-observation-nct07009860-2026-03-20-c02a1977625c"></a>
- **ClinicalTrials.gov record NCT07009860 · retained source version 2026-03-20:c02a1977625c558c78b022bf4ffb2fb17b8f36e6d148e6e732dd570f2188541e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07009860) (`ctg-observation-nct07009860-2026-03-20-c02a1977625c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07009860." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07009860-pemvidutide-v1.json SHA-256: 699f0aa1405b07ff0fd36a6e4f3b654877ffc1aec72a52063a857392274f123d.